PPT Slide
Safety/tolerability; optimal dosing schedule and maximum dose in patients
Double-blind, randomized, placebo-controlled
50 mg/kg q 4-day for 8 weeks (14 doses )
q 7-day for 13 weeks (14 doses )
100 mg/kg q 4-day for 4 weeks (7 doses )
q 7-day for 6 weeks (7 doses )
200 mg/kg q 4-day for 4 weeks (7 doses )
q 7-day for 6 weeks (7 doses )
34 patients with vascular disease and HDL-C 45 mg/dL